CSL Limited (ASX:CSL) and this ASX 50 share could be in the buy zone right now. Here’s what you need to know…
The post 2 ASX 50 shares to buy today appeared first on Motley Fool Australia. –
The S&P/ASX 50 index contains 50 of the largest listed companies on the Australian share market.
This includes many of the most well-known and highest quality companies in the ANZ region.
Two ASX 50 shares that come highly rated are listed below. Here’s what you need to know:
CSL Limited (ASX: CSL)
CSL is one of the world’s leading biotechnology companies. It has been a great place to invest over the last 10 years. Since this time in 2010, the CSL share price has generated an average total return of approximately 25% per annum.
This has been driven by its leading therapies and vaccines, its growing plasma collection network, and its high level of investment in research and development. In respect to the latter, CSL spent US$922 million on its research and development activities in FY 2020 and will invest even more this year. This is ensuring that its product pipeline is filled to the brim with potentially lucrative products.
One broker that is a fan of its research and development activities is UBS. It recently put a buy rating and $346.00 price target on its shares. It notes that product development has been a key driver of growth over the last few years and appears confident that this will be the case in the future.
Lendlease Group (ASX: LLC)
Lendlease is a global property and infrastructure company. Although its performance in FY 2020 was disappointing and led to the company reporting a loss of $310 million, its outlook is becoming increasingly positive.
This is due to the divestment of its struggling engineering business and the announcement of a major new strategy. The latter is shifting its earnings mix and business model favourably and looks to have positioned it perfectly for long term growth. This should be supported by some major urbanisation projects such as Thamesmead Waterfront in London and a partnership with Google in the San Francisco Bay Area.
One broker that is a fan of the strategy shift is Goldman Sachs. It recently put a buy rating and $16.74 price target on the company’s shares. The broker notes that its shares are trading at a discount to peers and expects this to narrow if it executes its new strategy successfully.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of June 30th
- ASX 200 expected to drop lower amid COVID-19 vaccine concerns
- Stockland (ASX:SGP) share price up 3% after new chief announced
- ASX stock winners from the $23 billion Victorian state budget
- Could Citi’s forecast spell good news for the Lendlease (ASX:LLC) share price?
- ASX 200 to rise after positive AstraZeneca COVID-19 vaccine news
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.